INJECTION DEVICE

An injection device comprises: a drug storer having a first space for storing a drug; a unidirectional switch having a second space in fluid communication with the first space; and an injection body having a third space in fluid communication with the second space, wherein the third space is provided with a piston adapted to move along the injection body, and to pump the drug stored in the first space into the third space. The drug storer comprises a base and a head cover, and at least one of the base and the head cover is formed by a flexible film, thereby forming the first space for storing a drug.

TECHNICAL FIELD

The disclosure relates to an injection device, and in particular to an injection device having a film liquid drug storage cavity.

BACKGROUND

At present, the volume utilization rate for a liquid drug in a cylindrical syringe drug storage cavity is low due to its shape characteristic. In the case of a given dosage, a designed drug pump generally has a large size. Prolonged use of a large drug pump will bring inconvenience to a patient's life, so that an oval syringe drug storage cavity attracts attention. However, although the oval syringe has improved the device size, the improvement is very limited. Moreover, due to stress changes along the circumference of the oval syringe, drug leakage occurs frequently. The requirements for machining precision of parts are also higher, thereby increasing the design difficulty and cost. Therefore, an improved liquid drug injection device is in urgent need.

SUMMARY

In order to solve the technical problem, the disclosure provides an improved injection device.

According to an embodiment of the disclosure, the injection device includes: a drug storer having a first space for storing a drug; a unidirectional switch having a second space in fluid communication with the first space; and an injection body having a third space in fluid communication with the second space, wherein the third space is provided with a piston adapted to move along the injection body, and to pump the drug stored in the first space into the third space.

According to the aspect of an embodiment, the drug storer includes a base and a head cover, wherein at least one of the base and the head cover is formed by a flexible film, thereby forming the first space.

According to the aspect of an embodiment, the base has a concave, and is a hard plastic base formed by polypropylene. The head cover is formed by a flexible film, which is pasted to the base by a hot pressing technology, thereby enabling the film and the concave to form the first space for storing a drug.

According to the aspect of an embodiment, both the base and the head cover are formed by the flexible film, and are pasted by a hot pressing technology to form the first space for storing a drug.

According to the aspect of an embodiment, the second space has a one-way valve arranged on a side proximate to the drug storer in the second space.

According to the aspect of an embodiment, on a side of the second space distal to the drug storer, a constant force providing device connected to the piston is arranged to push the piston to discharge the drug pumped into the third space.

According to the aspect of an embodiment, the constant force providing device includes a constant force spring, and the second space has a first operation state and a second operation state. In the first operation state, a pressure difference between the first space and the injection body is formed by pulling the constant force spring to turn on the unidirectional switch and pump the drug stored in the first space into the third space of the injection body; and in the second operation state, the compressed constant force spring provides a constant urging force to the piston, causing the piston to move towards a direction of the second space, and increasing the pressure in the second space. Due to the pressure difference between the second space and the first space, the unidirectional switch is turned off under a pressure in a forward direction. Moreover, the piston moves to push out a drug pumped thereinto.

According to the aspect of an embodiment, the unidirectional switch includes a sealing gasket arranged along an extension direction of the second space, a steel ball and a spring. The sealing gasket has an opening; and the steel ball is arranged against the spring, and seals the opening under the action of the spring.

According to the aspect of an embodiment, the constant force spring includes a sleeve, and a first spring and a second spring arranged inside the sleeve. The first spring has a smaller cross-section than a cross-section of the second spring, so that when the first spring and the second spring are compressed, the compressed first spring is compressed within the compressed second spring. The first spring and the second spring have an identical stiffness coefficient.

According to the aspect of an embodiment, the constant force spring has a small stiffness coefficient and a high compression ratio to ensure the spring having a very short operating stroke in the working process, thereby achieving the purpose of an approximate constant force.

According to an embodiment of the disclosure, the injection device further includes a flow rate limiter arranged in a drug fluid receiving direction of an injection body for limiting a flow rate of a liquid drug pushed out from the injection body.

According to the aspect of an embodiment, the flow rate limiter has a capillary structure to precisely and constantly effect the flow rate of the liquid drug by utilizing a flow rate limiting effect of the capillary.

According to the aspect of an embodiment, the flow rate limiter includes: a tubule for receiving the liquid drug pushed out from the injection body; and a column arranged in the tubule to form a gap with the inner wall of the tubule allowing the received liquid drug to pass through. The length of the column within the tubule is preset, thus adjusting the flow rate of the liquid drug passing through the gap.

According to an embodiment of the disclosure, the injection device further includes a quantifying syringe arranged in a drug fluid receiving direction of the injection body for accommodating and controlling a total quantity of a liquid drug pushed out from the injection body.

According to the aspect of an embodiment, the quantifying syringe includes: a volume body provided with a first passage and a second passage on both sides thereof; a fluid pipe having a fluid passage in fluid communication with the volume body through the first passage and the second passage; a pull rod provided with a center hole, an opening in fluid communication with the center hole, and sealing rings; a pressurized liquid inlet in fluid communication with the fluid passage or the center hole; and a normal pressure liquid outlet; wherein the pull rod moves along a longitudinal direction of the fluid passage, a gap is formed between the pull rod and the fluid passage, and a drug accommodation cavity is formed by the sealing rings between the pull rod and the fluid pipe. The normal pressure liquid outlet is in fluid communication with the fluid passage, so that a liquid drug discharged from the volume body to the cavity via the first passage and the second passage is discharged through the normal pressure liquid outlet.

According to the aspect of an embodiment, the volume body includes a first casing having a concave, a second casing having a concave, and a film arranged between the first casing and the second casing. The film isolates the volume body into a first volume body and a second volume body.

According to the aspect of an embodiment, when the pull rod is pushed, a pressurized liquid flows into the second volume body through the opening to push the film to move towards the first volume body, thus discharging a liquid accommodated in the first volume body through the first passage, and discharging the liquid discharged from the first volume body through the liquid outlet via the cavity. When the pull rod is pulled and then released, a pressurized liquid flows into the first volume body through the fluid passage to push the film to move towards the second volume body, thus discharging a liquid accommodated in the second volume body through the second passage, and discharging the liquid discharged from the second volume body through the liquid outlet via the cavity.

According to an embodiment of the disclosure, the injection device may further include a drug accommodation cavity in fluid communication with the injection body through a control valve, wherein a liquid drug in the drug accommodation cavity is controlled by the control valve and controllably filled in the injection body.

According to the aspect of an embodiment, the control valve may include a cavity and a second piston arranged in the cavity. A plurality of sealing rings may be arranged between the second piston and the cavity, and a spring device may be arranged at an end of the second piston, wherein when the second piston is pressed at a second end of the second piston, the spring device may be compressed, and the drug accommodation cavity is in fluid communication with the injection body through a gap between the sealing rings; and when the piston is released, the compressed spring device drives the second piston to return to an initial position, thus isolating the drug accommodation cavity from the injection body through the second sealing ring.

According to the aspect of an embodiment, the injection device may further include an indwelling needle catheter in fluid communication with the injection body through the control valve. When the second piston is pressed at a second end of the second piston, the spring device is compressed, the drug accommodation cavity is in fluid communication with the injection body through the gap between the second sealing ring and the third sealing ring, and the indwelling needle catheter is respectively isolated from the drug accommodation cavity and the injection body through the third sealing ring; and when the second piston is released, the compressed spring device drives the second piston to return to the initial position, thus isolating the drug accommodation cavity from the injection body through the second sealing ring, and the indwelling needle catheter is in fluid communication with the injection body through the gap between the second sealing ring and the third sealing ring.

According to the aspect of an embodiment, an injection system is provided. The injection system distributes the drug in the drug storer through the unidirectional switch to the injection body to realize large volume of quantitative output through a small size.

DETAILED DESCRIPTION OF EMBODIMENTS

The disclosure is further described in detail below in conjunction with the accompanying drawings and the embodiments. The embodiments described herein are only used for illustrating the invention, other than limiting the invention. Moreover, it is further necessary to explain that for the purpose of description, the accompanying drawings only show relevant parts related to the invention. Furthermore, in the scope of inspiration disclosed in the disclosure, features in the embodiments of the disclosure may be mutually combined, unless a conflict between technical solutions will be caused during mutual conflict. The disclosure is described in detail below by referring to the accompanying drawings and in conjunction with the embodiments.

FIG. 1is a schematic diagram showing an injection device according to an embodiment of the disclosure. As shown inFIG. 1, the injection device may include:

a drug storer10having a first space101for storing a drug;

a unidirectional switch20having a second space201in fluid communication with the first space101and being provided with a one-way valve; and

an injection body30having a third space301in fluid communication with the second space201and being provided with a piston40adapted to move along the injection body30,

wherein the unidirectional switch20is arranged on a side proximate to the drug storer10in the second space201, and a constant force providing device50, such as a constant force spring, is arranged on an opposite side distal to the drug storer10in the second space201.

FIG. 2is a partial enlarged drawing showing a drug storer10according to an embodiment of the disclosure.

The drug storer10includes a base102and a head cover103. The base102may be a hard plastic base formed by, e.g., polypropylene, and has a concave structure for forming a first space101accommodating a liquid drug therein. The head cover103may be a soft plastic film. A sealing paste is formed between the base102and the head cover103by a hot pressing method. A film drug storage cavity (i.e., the first space101) has a liquid drug inlet and a liquid drug outlet, and is in fluid communication with the second space201of the unidirectional switch20through the inlet and the outlet.

The drug storage cavity101thus formed may greatly increase the effective volume utilization rate to reduce the volume of the device at a given drug volume. Moreover, because the top, i.e., the head cover103, of the container is a soft plastic film, and is very easily deformed, the resistance is very small when a drug is extracted from the container cavity. This is very beneficial to designing a refillable member and operating a one-way valve.

FIG. 3shows a partial enlarged drawing of a drug storer according to another embodiment of the disclosure. In the embodiment shown inFIG. 3, both the base102and the head cover103are made of a film, thereby forming a drug storer10having a double-faced film structure. The drug storer10having a double-faced film structure can realize seamless fitting, thereby obtaining a more efficient drug utilization rate.

In an embodiment, the film drug storer10may store doses of, e.g., 3 to 6 days, while a syringe drug injection body only stores doses of, e.g., 1 day. A patient only needs to recharge the syringe drug injection body (recharge a liquid drug and potential energy of a spring) by pulling a piston (e.g., pulling a pull rod arranged in the piston) once every day. The whole device may provide a patient with a drug demand of, e.g., 4 days to 1 week.

Furthermore, the drug storage cavity fundamentally changing the volume utilization rate may be a non-barrel-shaped. The film drug storer formed by a hot pressing technology improves the volume rate to the greatest extent. The soft film is pasted by hot pressing to a casing formed by hard plastic injection molding, which may obtain a few advantages as follows:the volume rate is greatly improved;the volume and shape may be freely changed based on design requirements;the film deformation resistance is almost zero, and the pressure in the container may be considered as constant (barometric pressure);the manufacturing process is mature and reliable;the airtightness and safety may be simply tested and verified; andboth injection molding and hot pressing are low-cost technologies that may achieve quantity production.

The third space301of the injection body30has a first operation state and a second operation state. In the first operation state, a piston40, pulled by an external force, compresses a constant force providing device50to move towards a side of the injection body30proximate to the piston pull rod, causing a pressure in the injection body30to be smaller than a pressure in a first space101, thus turning on a one-way valve by a pressure difference between the first space101and the injection body30, and causing a drug stored in the first space101to be filled in the third space301of the injection body30. The external force pulls the piston pull rod and compresses the constant force providing device50to enable the system to store a potential energy of the spring as a power source of a pump.

In the second operation state, the external force applied to the piston disappears, the film drug storage cavity and the syringe drug injection body are in an environment of an identical barometric pressure, and the pressure difference between both is completely provided by the constant force providing device. Under the circumstance, the compressed constant force spring pushes the piston to move to a side proximate to the second space201, so that the syringe drug injection body becomes a pressure cavity, the one-way valve is turned off under a pressure in a forward direction, and the pressurized liquid drug cannot flow through the one-way valve, but only flow to a flow rate limiter and a quantifying syringe.

FIG. 4is an enlarged schematic diagram of a one-way valve according to an embodiment of the disclosure. As shown in the figure, a unidirectional switch20has a second space201, and a sealing gasket211(e.g., a silica gel sealing gasket), a steel ball212and a spring213are arranged along an extension direction of the second space201. The sealing gasket211is provided with an opening allowing a liquid drug to circulate between a drug accommodation space of a drug storer10and a space of a unidirectional switch. The steel ball212, pushed by the spring213, presses and seals the opening. The second space201has a passageway214wound by a passageway wall215, so that the second space201is in fluid communication with a third space301of the injection body30through the passageway214. As shown in the figure, the spring213is arranged against an end of the passageway wall215.

FIG. 5is a schematic diagram showing an injection device having a flow rate limiter60and a quantifying syringe80according to an embodiment of the disclosure. A constant force providing device50is directly fixed to a drug piston40. The constant force providing device50can apply a constant force to the drug piston40, pushing the piston40to move along an extension direction of a space (a third space301), and pushing out a drug in an injection body30. An injection body30independently driven through pressurization by a constant force spring effects injection to a patient at a constant flow rate through the flow rate limiter60. The injection body30driven through pressurization by the constant force spring effects timely quantitative injection to a patient by a manual quantifying syringe80.

In an embodiment, a constant force providing device50may be, e.g., a constant force spring. As shown inFIG. 6, the constant force spring includes a sleeve501, and a first spring502(small) and a second spring503(large) respectively arranged inside the sleeve501. The sleeve may be made of metal or plastic, such as ABS. A projection5031for limiting the second spring503and a projection5032for limiting the first spring502are provided at an end of the sleeve501. The first spring502and the second spring503are connected adjacently inside the sleeve, and the first spring502(small) has a smaller cross-section than a cross-section of the second spring503(large), so that when the two springs are compressed, the compressed first spring502(small) is compressed within the compressed second spring503(large). The two springs maybe made of an ordinary spring steel or stainless steel, and have an identical stiffness coefficient.FIG. 6further separately shows a schematic diagram of a configured structure of the sleeve501and a state of gradually compressing the first spring502(small) and the second spring503(large).

Because of size limitation, in certain cases, the space left to the spring is limited in the device. The constant force spring design needs to increase the free length of the spring as much as possible, so the compressed length of the spring is increased accordingly. The design of a spring sleeved inside another spring as shown in the figure is used: a spring having a larger diameter is in the outside, a spring having a slightly smaller diameter is in the inside, and the two springs are connected end to end with a connecting sleeve to greatly increase the length of the springs under the condition of a given size.

Assume that a free length of the spring having a large diameter is L1, and its compressed length is L0; a free length of the spring having a small diameter is L2, and its compressed length is also L0; and a length of the connecting sleeve is approximately equal to L0. Then a total free length of the assembled spring is L1+L2−L0, its compressed length is L0, and the total compressed length in the working state is L=L1+L2−2×L0.

If the spring stroke is ΔL=20 MM,

then the error=ΔL/L=20÷300=0.067=±3.3%.

If a single spring, instead of a composite spring design, is used, then

When the same stroke is ΔL=20 MM,

a much larger error=ΔL/L=20÷175=0.114=±5.7% will be obtained.

FIG. 7shows a schematic diagram of a spring useful for a constant force providing device according to an embodiment of the disclosure. The spring R has a small stiffness coefficient and a high compression ratio to facilitate achieving the purpose of an approximate constant force by a very short operating stroke of the spring R.

As shown inFIG. 7, the free length of the spring R is L1, the length of the spring is compressed to L2when the spring R works under the action of a drug piston40, and the working length of the spring is ΔL. When a spring having a stiffness coefficient of k is used, the pressure difference (error) in the actual working process may be calculated by the following formula:

As can be seen from the formula, the error may be reduced by reducing the stiffness coefficient and shortening the operating stroke ΔL. Therefore, in an embodiment of the invention, the spring having a small stiffness coefficient is used and a short stroke is used to effect an approximate constant force spring.

In an embodiment, a flow rate limiter60may have a capillary structure to precisely and constantly effect the flow rate by utilizing a flow rate limiting effect of the capillary, i.e., compensating for an inner diameter error using a length. When a fluid passes through a tubule having a round cross-section very slowly, such a flow is laminar flow. An exact solution of the laminar flow in the round tube may be obtained using an analytical method. The flow rate of the fluid in the round tube is associated with the pressure difference at both ends of the tube, the viscosity of the fluid per se, the length of the tube and the diameter of the round tube. When it is used as a flow rate limiter, the exact flow rate may be calculated by the following equation:

ΔP: Pressure drop on the flow rate limiter60(psi)

η: Viscosity of a liquid passing through the flow rate limiter60(cp)

L: Length of the round tube of the flow rate limiter60

D: Radius of the round tube (μm)

In another embodiment, as shown inFIG. 8, the flow rate limiter60may include a capillary601and a column (such as metal wire)602inserted into the capillary601. A gap allowing a liquid drug to circulate is formed between the capillary601and the inserted column602. For example, the capillary601may be, for instance, a round tube, the column602may be, for instance, a cylinder, and then the round tube and the inserted cylinder form a tubular flow rate limiter of an annular flow.

The flow rate limiter60adjusts the flow rate of the flow rate limiter through a stack length L of the round tube and the cylinder. It should be understood that the stack length L may be preset based on specific needs. When the flow rate is slow (laminar flow), the liquid flow rule in the annular flow tube is:

Q: Flow rate

Δp: Pressure drop on the flow rate limiter

H: Viscosity of the liquid flowing through the flow rate limiter

L: Length of the flow rate limiter: stack length of the round tube and the cylinder

Ro: Radius of the round tube

Ri: Radius of the cylinder

Ln: logarithm of a natural number to base e

Further returning toFIG. 5, an indwelling needle hose70may also be provided in the fluid outflow direction of the flow rate limiter60for transporting a liquid drug to a human body by a needle connected to the interface. The needle hose70may be in fluid communication with the flow rate limiter60by conventional connection means. By a flow rate limiting effect of the flow rate limiter60, the liquid drug accommodated in the injection body30may be continuously discharged at a constant flow rate under a pressure provided by the constant force spring via the indwelling needle hose70.

FIG. 9andFIG. 10show an enlarged view of the quantifying syringe80according toFIG. 5. The quantifying syringe80includes a volume body801having a first passage L1and a second passage L2. The volume body801includes a first casing810ahaving a concave, a second casing810bhaving a concave, and a film812arranged between the first casing810aand the second casing810b.The shape of the first casing810acorresponds to the shape of the second casing810b.The film812is hot pressed between the first casing810aand the second casing810bby a hot pressing technology, causing the two casings to be pasted and isolate the volume body801into a first volume body and a second volume body. Thus, the volume body801has a one-way valve function. The quantifying syringe80further includes a fluid pipe having a fluid passage802, a spring pull rod803having a cylindrical valve, a pressurized liquid inlet804, a normal pressure liquid outlet805and a drug accommodation cavity806. The pull rod803includes a center hole807, an opening808connected to the center hole807, and sealing rings809a-c.The pressurized liquid inlet is in fluid communication with the center hole807of the pull rod803. A gap may be formed between a passageway807and the pull rod803by sealing using the sealing rings809aand809b.

As shown inFIG. 9, when the pull rod803is pushed by overcoming a spring force, the opening808on the pull rod803and connected to the center hole807is in fluid communication with the second passage L2of the volume body801. A pressurized liquid flows into the second volume body801bthrough the opening808to push the film812to move towards the first volume body801, thus discharging a liquid accommodated in the first volume body801ato the passageway807through the first passage L1. The discharged liquid is discharged through the liquid outlet805via the cavity806between the fluid passage802and the pull rod803.

As shown inFIG. 10, when the spring pull rod is released to return to an initial position, the opening808on the pull rod803is disconnected with the second passage L2of the volume body801, and the first passage L1of the volume body801is in fluid communication with the pressurized liquid inlet, so that a fluid flows into the first volume body801athrough the first passage L1. A liquid flowing into the first volume body801apushes the film812to move towards the second volume body801b,thus discharging a liquid accommodated in the second volume body801bthrough the second passage L2. The discharged liquid is discharged through the liquid outlet805via the cavity806between the fluid passage802and the pull rod803.

Therefore, the liquid in the volume body801is discharged into a corresponding pipe when the pressure difference is transferred each time. In a round of operation of pushing the pull rod803to compress a spring and then the spring automatically returning, two volume bodies of a liquid drug will be discharged through the normal pressure liquid outlet805via the pipe. An impetus driving the liquid drug is a pressure of the liquid at the inlet804. Therefore, the inlet804of the device must be operated by a pressurized liquid. The number of times of pushing the pull rod802determines a volume of the discharged liquid. The device does not have a leak passageway, so all sealing elements may be very easily tested and verified during debugging. Because the liquid drug discharged each time is only associated with the volume of the cavity formed by injection molding, but is not associated with operation and environmental parameters (such as pressure, speed and temperature), the volume of the discharged liquid drug is very accurate.

When it is used, for example, two units of insulin may be injected by pushing the spring once and after the spring returns. For example, if pre-meal injection of eight units of insulin is required, then it is only necessary to push the pull rod803four times.

According to an embodiment described herein, a design of recharging both a liquid drug and a potential energy of a spring may be achieved by manually (or electrically) pulling a piston pull rod. Timely quantitative injection to a patient may be accurately realized using a safety design of mutually deadlocking a film-partitioning shallow arc-shaped cavity having a fixed volume and a communicating valve, as well as a design of fitting between a cylindrical communicating valve and a film-partitioning arc-shaped cavity. A fitting between a film storage cavity having a large volume and zero resistance and a cylindrical injection body having a small volume enables a constant force spring to be an easily realized design.

In order to further increase the volume of the injection device, a refillable spring-driven pump controlled by a control valve may be further provided.

FIG. 11shows a schematic diagram of a refillable spring-driven pump controlled by a control valve.

As shown inFIG. 11, a refillable spring-driven pump90controlled by a valve may include a drug accommodation cavity901in fluid communication with an injection body30through a control valve903. A piston904is arranged in the drug accommodation cavity901, and a non-constant force spring909for driving the piston904to move along the accommodation cavity901is arranged at an end of the piston distal to the control valve903. A spring force of the non-constant force spring909needs to be enough to overcome a spring force of the drug injection body to inject a liquid drug into the injection body30.

The control valve903includes a cavity906and a second piston907arranged in the cavity906. A plurality of sealing rings902a,902band902care arranged between the second piston907and the cavity906. A spring device908is arranged at an end of the second piston907. When it is necessary to inject a liquid drug into the drug injection body30, the second piston907is pressed at a second end of the second piston907from an initial position shown inFIG. 10, causing the spring device908to be compressed. Under the circumstance, the drug accommodation cavity901is in fluid communication with the drug injection body30through a gap between the second sealing ring902band the third sealing ring902c,causing the drug to flow from the drug accommodation cavity901into the injection body30. When the piston is released, the compressed spring device908drives the second piston to return to its initial position, thus isolating the drug accommodation cavity901from the injection body30through the second sealing ring902b.

In the spring-driven pump shown inFIG. 11, a valve return spring of the control valve doesn't need to be a constant force spring, and is OK as long as it can overcome a friction force of a sealing ring to enable the control valve to return to the initial position after being pressed.

FIG. 12shows another embodiment of the spring-driven pump according toFIG. 11.

Different from the embodiment shown inFIG. 11, a plurality of sealing rings902a,902b,902cand902dare arranged between the second piston907and the cavity906, and an indwelling needle catheter905in fluid communication with the injection body30is connected to the cylindrical control valve903. When a liquid drug is injected into the drug injection body30, the second piston907is pressed at an end of the second piston907opposite to the spring device from the initial position, causing the spring device908to be compressed (as shown inFIG. 11). Under the circumstance, the drug accommodation cavity901is in fluid communication with the drug injection body30through the gap between the second sealing ring902band the third sealing ring902c,and the indwelling needle catheter905may be respectively isolated from the drug accommodation cavity901and the drug injection body30through the third sealing ring902c,thereby ensuring the drug not to flow into the indwelling needle catheter905when the liquid drug is injected. When the second piston907is released, the compressed spring device908drives the second piston907to return to the initial position, thus isolating the drug accommodation cavity901from the drug injection body30through the second sealing ring902b,and the injection body30is in fluid communication with the indwelling needle catheter905through the gap between the second sealing ring902band the third sealing ring902c,enabling the liquid drug filled in the drug injection body to be injected into a patient's body through the indwelling needle.

With such a design of driving the drug injection body by the drug accommodation cavity, the foregoing flow rate limiter may be arranged at an outlet of the drug injection body to achieve the purpose of sustained release of a drug. This may realize injection of an essential drug (such as insulin) at a desired constant flow rate. If a flow rate limiter is not arranged at an outlet of the drug injection body, then a given quantity may be injected instantly at a time when the control valve is operated. Such an injection may satisfy the need for, e.g., pre-meal drug injection.

For the flow rate limiter, because the error of the whole system is calculated based on the injection body volume, instead of the flow rate, the precision of the flow rate limiter, the precision of the injection body spring and the like are no longer important. Therefore, it is not necessary to design the flow rate limiter to be adjustable, nor is a debugging process required in the whole process of assembling the device. The accuracy of the system may be guaranteed by the volume of the drug injection body.

A drug injection device and a drug injection device system according to the embodiments of the disclosure are described above. However, it should be understood that the above description only provides embodiments to implement the invention, other than to limit the invention. Any modification, equivalent replacement, improvement and the like of the invention within the spirit and principle of the invention shall be included in the scope of protection of the invention.